心脏植入电子设备（CIED）手术中直接口服抗凝剂的继续使用与中断：新型抗凝剂，旧困境。 - Suppr

Suppr

超能文献

Continuation Versus Interruption of Direct Oral Anticoagulants for CIED Procedures: New Anticoagulants, Old Dilemma.

作者信息

Tonko Johanna B, Wright Matthew J

机构信息

Department of Cardiology, St Thomas' Hospital, London, United Kingdom.

School of Biomedical Engineering & Imaging Sciences, King's College London, London, United Kingdom.

出版信息

JACC Case Rep. 2021 Jul 21;3(8):1141-1144. doi: 10.1016/j.jaccas.2021.06.004.

DOI:10.1016/j.jaccas.2021.06.004

PMID:34471900

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8314125/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2741/8314125/23b549ec7948/fx1.jpg

相似文献

Continuation Versus Interruption of Direct Oral Anticoagulants for CIED Procedures: New Anticoagulants, Old Dilemma.心脏植入电子设备（CIED）手术中直接口服抗凝剂的继续使用与中断：新型抗凝剂，旧困境。

JACC Case Rep. 2021 Jul 21;3(8):1141-1144. doi: 10.1016/j.jaccas.2021.06.004.

Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.接受心脏植入式电子设备植入的心房颤动患者的口服抗凝管理。

Clin Cardiol. 2017 Sep;40(9):746-751. doi: 10.1002/clc.22726. Epub 2017 May 19.

Safety and Efficacy of Transcatheter Aortic Valve Replacement With Continuation of Vitamin K Antagonists or Direct Oral Anticoagulants.维生素K拮抗剂或直接口服抗凝剂持续使用情况下经导管主动脉瓣置换术的安全性和有效性

JACC Cardiovasc Interv. 2021 Jan 25;14(2):135-144. doi: 10.1016/j.jcin.2020.09.062. Epub 2020 Dec 23.

Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial.继续使用华法林在起搏器或植入式心脏除颤器植入期间：一项随机临床试验。

Heart Rhythm. 2011 Apr;8(4):536-40. doi: 10.1016/j.hrthm.2010.12.016. Epub 2010 Dec 13.

Pocket hematoma after pacemaker or defibrillator surgery: Direct oral anticoagulants versus vitamin K antagonists.起搏器或除颤器植入术后的皮下血肿：直接口服抗凝剂与维生素K拮抗剂的比较

Int J Cardiol Heart Vasc. 2022 Mar 16;39:101005. doi: 10.1016/j.ijcha.2022.101005. eCollection 2022 Apr.

Thromboembolic and bleeding risks in edoxaban patients with pacemaker and cardiac monitoring procedures: Outcomes of the Global EMIT program.依度沙班患者行起搏器和心脏监测程序的血栓栓塞和出血风险：全球 EMIT 项目的结果。

Pacing Clin Electrophysiol. 2022 Jan;45(1):83-91. doi: 10.1111/pace.14381. Epub 2021 Dec 26.

Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.在达比加群不间断使用情况下进行心血管植入式电子设备植入：与华法林不间断使用情况的比较

J Cardiovasc Electrophysiol. 2013 Oct;24(10):1125-9. doi: 10.1111/jce.12214. Epub 2013 Jul 25.

Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures.低出血风险操作中直接口服抗凝剂的临时中断与持续比较。

Thromb Res. 2021 Jul;203:27-32. doi: 10.1016/j.thromres.2021.04.006. Epub 2021 Apr 19.

Interrupted versus uninterrupted novel oral anticoagulant peri-implantation of cardiac device: A single-center randomized prospective pilot trial.心脏装置植入围手术期新型口服抗凝药间断与不间断给药的比较：一项单中心随机前瞻性试点试验。

Pacing Clin Electrophysiol. 2018 Nov;41(11):1476-1480. doi: 10.1111/pace.13482. Epub 2018 Sep 19.

Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.维生素 K 拮抗剂和直接口服抗凝剂的围手术期管理：系统评价和荟萃分析。

Chest. 2023 May;163(5):1245-1257. doi: 10.1016/j.chest.2022.11.032. Epub 2022 Dec 1.

引用本文的文献

Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion.心脏节律管理设备植入时的间断抗凝与持续抗凝

Cochrane Database Syst Rev. 2025 Jan 28;1(1):CD013816. doi: 10.1002/14651858.CD013816.pub2.

本文引用的文献

Exposed Hematoma After Pacemaker Generator Change.起搏器发生器更换后出现外露血肿。

JACC Case Rep. 2021 Jul 21;3(8):1139-1140. doi: 10.1016/j.jaccas.2021.03.021.

Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma: Combined Analysis of BRUISE CONTROL 1 and 2.直接口服抗凝剂、华法林和抗血小板药物对装置袋血肿风险的影响：BRUISE CONTROL 1 和 2 的联合分析。

Circ Arrhythm Electrophysiol. 2019 Oct;12(10):e007545. doi: 10.1161/CIRCEP.119.007545. Epub 2019 Oct 15.

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.接受直接口服抗凝剂治疗的房颤患者的围手术期管理

JAMA Intern Med. 2019 Nov 1;179(11):1469-1478. doi: 10.1001/jamainternmed.2019.2431.

Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.抗菌包膜预防心脏植入式电子设备感染。

N Engl J Med. 2019 May 16;380(20):1895-1905. doi: 10.1056/NEJMoa1901111. Epub 2019 Mar 17.

Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).在中度至高度发生动脉血栓栓塞事件风险的患者中，在器械手术时继续使用或中断直接口服抗凝剂（BRUISE CONTROL-2）。

Eur Heart J. 2018 Nov 21;39(44):3973-3979. doi: 10.1093/eurheartj/ehy413.

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.利伐沙班联合或不联合阿司匹林用于稳定性冠心病患者：一项国际、随机、双盲、安慰剂对照试验。

Lancet. 2018 Jan 20;391(10117):205-218. doi: 10.1016/S0140-6736(17)32458-3. Epub 2017 Nov 10.

To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: reply.术前或侵入性操作前是否检测直接口服抗凝剂：回复

J Thromb Haemost. 2017 Jan;15(1):202-204. doi: 10.1111/jth.13572. Epub 2017 Jan 13.

To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: comment.术前或侵入性操作前是否检测直接口服抗凝剂：评论

J Thromb Haemost. 2016 Dec;14(12):2556-2559. doi: 10.1111/jth.13505. Epub 2016 Oct 24.

Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study.临床显著的囊袋血肿会增加器械感染的长期风险：BRUISE CONTROL INFECTION 研究。

J Am Coll Cardiol. 2016 Mar 22;67(11):1300-8. doi: 10.1016/j.jacc.2016.01.009.

Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies.接受电生理设备植入的华法林长期抗凝患者发生囊袋血肿的风险：不同围手术期管理策略的比较

Eur Rev Med Pharmacol Sci. 2015 Apr;19(8):1461-79.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验